Aurobindo: US Tariffs ‘Not A Challenge’ For Now, Scouting For Biosimilars Tie-Ups

‘Entire’ GLP-1 Range Including Semaglutide To Be Launched

 
• By Vibha Ravi
  
US Tariffs Are Leading To Fears Of Business Disruption
US Tariffs Are Leading To Fears Of Business Disruption (Shutterstock)

More from Earnings

More from Policy & Regulation